Tag: biosimilar vs generic
Adverse Event Monitoring for Biosimilars: How Safety Surveillance Keeps Patients Protected
By Joe Barnett On 3 Feb, 2026 Comments (15)
Biosimilars aren't like generics-they need advanced safety monitoring to track immune reactions and ensure patient safety. Learn how adverse event reporting, traceability, and AI-driven surveillance keep these complex drugs safe in real-world use.
View More
